Anti-Tumor Necrosis Factor-α Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia

Anti-Tumor Necrosis Factor-α Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia

Psoriasis is a chronic immunologically-based inflammatory skin disease. B-chronic lymphocytic leukemia (B-CLL) is a form of leukemia characterized by the slow and progressive accumulation of monoclonal CD5+ B lymphocytes in peripheral blood, bone marrow, lymph nodes and other organs. A T-helper 1 cy...

Full description

Bibliographic Details
Main Authors: Anna Balato, Serena Lembo, Teresa Cirillo, Matteo Megna, Annunziata Raimondo, Luisa Di Costanzo
Format: Article
Language:English
Published: Karger Publishers 2011-03-01
Series:Case Reports in Dermatology
Subjects:
Tumor necrosis factor-α
Anti-TNF-α drugs
B-chronic lymphocytic leukemia
Psoriasis
Online Access:http://www.karger.com/Article/FullText/324344

Similar Items

Similar Items